ENDRA Life Sciences (NDRA) Net Cash Flow Growth (5y) (2021 - 2026)
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Net Cash Flow Growth (5y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 30.96% |
| Mar 31, 2026 | -15.35% |
| Dec 31, 2025 | -14.98% |
| Sep 30, 2025 | -18.47% |
| Jun 30, 2025 | 35.82% |
| Mar 31, 2025 | 17.63% |
| Dec 31, 2024 | -19.02% |
| Sep 30, 2024 | -192.75% |
| Jun 30, 2024 | 38.93% |
| Mar 31, 2024 | 7.77% |
| Dec 31, 2023 | -15.84% |
| Sep 30, 2023 | 1.09% |
| Jun 30, 2023 | 35.75% |
| Mar 31, 2023 | -0.66% |
| Dec 31, 2022 | -17.85% |
| Sep 30, 2022 | -42.94% |
| Jun 30, 2022 | -10.90% |
| Mar 31, 2022 | -190.54% |
| Dec 31, 2021 | -33.68% |
| Sep 30, 2021 | -69.60% |